These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15639632)

  • 1. Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis.
    Altman RD; Abadie E; Avouac B; Bouvenot G; Branco J; Bruyere O; Calvo G; Devogelaer JP; Dreiser RL; Herrero-Beaumont G; Kahan A; Kreutz G; Laslop A; Lemmel EM; Menkes CJ; Pavelka K; Van De Putte L; Vanhaelst L; Reginster JY;
    Osteoarthritis Cartilage; 2005 Jan; 13(1):13-9. PubMed ID: 15639632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.
    Abadie E; Ethgen D; Avouac B; Bouvenot G; Branco J; Bruyere O; Calvo G; Devogelaer JP; Dreiser RL; Herrero-Beaumont G; Kahan A; Kreutz G; Laslop A; Lemmel EM; Nuki G; Van De Putte L; Vanhaelst L; Reginster JY;
    Osteoarthritis Cartilage; 2004 Apr; 12(4):263-8. PubMed ID: 15023377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis.
    Gossec L; Hawker G; Davis AM; Maillefert JF; Lohmander LS; Altman R; Cibere J; Conaghan PG; Hochberg MC; Jordan JM; Katz JN; March L; Mahomed N; Pavelka K; Roos EM; Suarez-Almazor ME; Zanoli G; Dougados M
    J Rheumatol; 2007 Jun; 34(6):1432-5. PubMed ID: 17552070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugs.
    Dougados M; Hawker G; Lohmander S; Davis AM; Dieppe P; Maillefert JF; Gossec L
    J Rheumatol; 2009 Sep; 36(9):2097-9. PubMed ID: 19738220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon) as a structure modifying therapy in osteoarthritis of the hip and knee.
    Pavelká K; Gatterová J; Gollerova V; Urbanová Z; Sedlácková M; Altman RD
    Osteoarthritis Cartilage; 2000 Sep; 8(5):335-42. PubMed ID: 10966839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of total hip and total knee replacements from the prospective epidemiologic risk factor study: considerations for event driven clinical trial design.
    Bager CL; Karsdal M; Bihlet A; Thudium C; Byrjalsen I; Bay-Jensen AC
    BMC Musculoskelet Disord; 2019 Jun; 20(1):303. PubMed ID: 31238943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular cell adhesion molecule 1 as a predictor of severe osteoarthritis of the hip and knee joints.
    Schett G; Kiechl S; Bonora E; Zwerina J; Mayr A; Axmann R; Weger S; Oberhollenzer F; Lorenzini R; Willeit J
    Arthritis Rheum; 2009 Aug; 60(8):2381-9. PubMed ID: 19644856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint replacement surgery in elderly patients with severe osteoarthritis of the hip or knee: decision making, postoperative recovery, and clinical outcomes.
    Hamel MB; Toth M; Legedza A; Rosen MP
    Arch Intern Med; 2008 Jul; 168(13):1430-40. PubMed ID: 18625924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of total joint arthroplasty and joint preserving surgery in younger patients evaluated by alternative outcome measures.
    Klit J
    Dan Med J; 2014 Apr; 61(4):B4836. PubMed ID: 24814600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group.
    Gossec L; Paternotte S; Bingham CO; Clegg DO; Coste P; Conaghan PG; Davis AM; Giacovelli G; Gunther KP; Hawker G; Hochberg MC; Jordan JM; Katz JN; Kloppenburg M; Lanzarotti A; Lim K; Lohmander LS; Mahomed NN; Maillefert JF; Manno RL; March LM; Mazzuca SA; Pavelka K; Punzi L; Roos EM; Rovati LC; Shi H; Singh JA; Suarez-Almazor ME; Tajana-Messi E; Dougados M;
    J Rheumatol; 2011 Aug; 38(8):1765-9. PubMed ID: 21807799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of health-related quality of life after surgical treatment of focal symptomatic spinal stenosis compared with osteoarthritis of the hip or knee.
    Rampersaud YR; Ravi B; Lewis SJ; Stas V; Barron R; Davey R; Mahomed N
    Spine J; 2008; 8(2):296-304. PubMed ID: 17669690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of alternative clinical pathways for primary hip and knee joint replacement patients: a pragmatic randomized, controlled trial.
    Gooch K; Marshall DA; Faris PD; Khong H; Wasylak T; Pearce T; Johnston DW; Arnett G; Hibbert J; Beaupre LA; Zernicke RF; Frank C
    Osteoarthritis Cartilage; 2012 Oct; 20(10):1086-94. PubMed ID: 22796513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative analysis of patient-centered outcome of total hip and knee arthroplasty].
    Wollmerstedt N; Glatzel M; Kirschner S; Schneider J; Faller H; König A
    Z Orthop Ihre Grenzgeb; 2006; 144(5):464-71. PubMed ID: 16991061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in presentation, progression and rates of arthroplasty between hip and knee osteoarthritis: Observations from an osteoarthritis cohort study-a clear role for conservative management.
    Dabare C; Le Marshall K; Leung A; Page CJ; Choong PF; Lim KK
    Int J Rheum Dis; 2017 Oct; 20(10):1350-1360. PubMed ID: 28493422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hip joint replacement surgery for idiopathic osteoarthritis aggregates in families.
    Bukulmez H; Matthews AL; Sullivan CM; Chen C; Kraay MJ; Elston RC; Moskowitz RW; Goldberg VM; Warman ML
    Arthritis Res Ther; 2006; 8(1):R25. PubMed ID: 16507126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sports activities 5 years after total knee or hip arthroplasty: the Ulm Osteoarthritis Study.
    Huch K; Müller KA; Stürmer T; Brenner H; Puhl W; Günther KP
    Ann Rheum Dis; 2005 Dec; 64(12):1715-20. PubMed ID: 15843453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of total knee and hip replacement for osteoarthritis in relation to circulating sex steroid hormone concentrations in women.
    Hussain SM; Cicuttini FM; Bell RJ; Robinson PJ; Davis SR; Giles GG; Graves S; Milne RL; Wang Y
    Arthritis Rheumatol; 2014 Aug; 66(8):2144-51. PubMed ID: 24692288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs.
    Brandt KD; Mazzuca SA
    Arthritis Rheum; 2005 Nov; 52(11):3349-59. PubMed ID: 16258927
    [No Abstract]   [Full Text] [Related]  

  • 19. Which patients are most likely to benefit from total joint arthroplasty?
    Hawker GA; Badley EM; Borkhoff CM; Croxford R; Davis AM; Dunn S; Gignac MA; Jaglal SB; Kreder HJ; Sale JE
    Arthritis Rheum; 2013 May; 65(5):1243-52. PubMed ID: 23459843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The progression of end-stage osteoarthritis: analysis of data from the Australian and Norwegian joint replacement registries using a multi-state model.
    Gillam MH; Lie SA; Salter A; Furnes O; Graves SE; Havelin LI; Ryan P
    Osteoarthritis Cartilage; 2013 Mar; 21(3):405-12. PubMed ID: 23274101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.